|
|
||||||||||||||
|
|
|||||||||||||||
Therapeutics |
Clinical impact ratings GP/FP/Primary care






Allergy & immunology 





Paediatrics 





Key Words: asthma
| The first 150 words of the full text of this article appear below. |
METHODS
Design:
randomised, 2x2 factorial design, placebo controlled trial.
Allocation:
{concealed*}
.
Blinding:
blinded {participants [diet intervention only], outcome assessors, and laboratory staff}
.*
Follow up period:
5 years.
Setting:
{antenatal clinics of 6 hospitals in Sydney, Australia.}
Participants:
616 pregnant women (mean age 29 y), whose unborn singleton child was at increased risk of developing asthma because of asthma or frequent wheezing in a first degree relative. Exclusion criteria included a cat in the home and a vegetarian diet. Infants born at <36 weeks gestation, with birth weight <2.5 kg or significant congenital malformation or neonatal disease were withdrawn.
Interventions:
active HDM intervention (n = 308), consisting of an allergen impermeable barrier on the childs bed and pillow, regular washing of bedding, and use of a benzyl benzoate containing solution in the wash every 3 months; or control HDM (n = 308), consisting of usual care. Active
Thomas M Ball, MD, MPH
University of Arizona, Tucson, Arizona, USA
Related Article
Evid. Based Med. 2007 12: 31-32.
(in )
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |